宗旨和范围
The Annals of Pharmacotherapy is a peer-reviewed medical journal covering all aspects of pharmacotherapy. The journal was established in 1967 as Drug Intelligence. The name changed a few times during its history, to Drug Intelligence and Clinical Pharmacy (DICP) in 1969 and DICP-The Annals of Pharmacotherapy in 1989, before obtaining its current name in 1992. Less
关键指标
期刊详情
- 出版商SAGE PUBLICATIONS INC
- 出版语言Multi-Language
- 出版频率Monthly
- 出版语言Multi-Language
- 出版频率Monthly
- 创刊年份1967
- Publisher URL
- 网址
Topics Covered
常见问题
Annals of Pharmacotherapy 是从何时开始发行的? ![Faqs](assets/images/arrow-down.svg)
Annals of Pharmacotherapy 自1967开始发行至今。
Annals of Pharmacotherapy 多久发行一次? ![Faqs](assets/images/arrow-down.svg)
Annals of Pharmacotherapy 为Monthly。
Annals of Pharmacotherapy 的 H 指数、SNIP 指数、Citescore 和 SJR 分别是多少? ![Faqs](assets/images/arrow-down.svg)
Annals of Pharmacotherapy 的H指数为 120、 Citescore 为 5、SNIP 指数为1.15 、 SJR 为 Q1。
Annals of Pharmacotherapy 的出版商是谁? ![Faqs](assets/images/arrow-down.svg)
Annals of Pharmacotherapy 的出版商是SAGE PUBLICATIONS INC。
我在哪里查看 Annals of Pharmacotherapy 的宗旨和范围? ![Faqs](assets/images/arrow-down.svg)
查看 Annals of Pharmacotherapy 的宗旨和范围,请点击此处。
我如何在意得辑上查看Annals of Pharmacotherapy 的指标? ![Faqs](assets/images/arrow-down.svg)
查看 Annals of Pharmacotherapy 的指标,请单击此处。
Annals of Pharmacotherapy 的 eISSN和pISSN 号分别是什么? ![Faqs](assets/images/arrow-down.svg)
1542-6270 的 eISSN 为 1060-0280,pISSN 为 Annals of Pharmacotherapy 。
该期刊重点关注哪些主题? ![Faqs](assets/images/arrow-down.svg)
本期刊关注的主题范围广泛,包括 Anticoagulant, Albumin, Acne, Clinical trial, Heparin, Percutaneous coronary intervention, Type 2 diabetes, Atrial fibrillation, Sepsis, Nonsteroidal, Odds ratio, Warfarin, Intensive care, Pulmonary hypertension, Clostridium difficile, Breast cancer, Melatonin, Body mass index, Intensive care unit, Vasopressin。
为什么搜索适合我研究的期刊很重要? ![Faqs](assets/images/arrow-down.svg)
选择与您研究领域紧密相关的期刊,有助于确保您的学术成果能够触及最合适的读者群体, 从而最大化您的学术影响力和对该领域的贡献。
对期刊的选择会影响我的学术事业吗? ![Faqs](assets/images/arrow-down.svg)
当然。在知名期刊上发表论文可提升您的学术形象, 使您在获取资助、终身教职和其他职业机会方面更具竞争力。
只考虑具有高影响力的期刊是否明智? ![Faqs](assets/images/arrow-down.svg)
虽然高影响力的期刊知名度高,但投稿竞争也相对激烈。因此, 关键在于权衡考虑期刊的影响因子与论文被接受的可能性。